Programming the magnitude and persistence of antibody responses with innate immunity-Reference-Cited by-同舟云学术

Programming the magnitude and persistence of antibody responses with innate immunity

Published:2011-02 Issue:7335 Volume:470 Page:543-547
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Kasturi Sudhir Pai,Skountzou Ioanna,Albrecht Randy A.,Koutsonanos Dimitrios,Hua Tang,Nakaya Helder I.,Ravindran Rajesh,Stewart Shelley,Alam Munir,Kwissa Marcin,Villinger Francois,Murthy Niren,Steel John,Jacob Joshy,Hogan Robert J.,García-Sastre Adolfo,Compans Richard,Pulendran Bali

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09737.pdf

Reference56 articles.

1. Pulendran, B. & Ahmed, R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124, 849–863 (2006)

2. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 11, 373–384 (2010)

3. Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nature Rev. Immunol. 9, 741–747 (2009)

4. Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413–424 (2006)

5. Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature Immunol. 10, 116–125 (2009)

Cited by 819 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity;Biomaterials;2024-12

2. Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine;2024-09-07

3. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

4. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses;Science Advances;2024-08-09

5. Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy;Advanced Science;2024-08-08